Medicine and Dentistry
Patient
100%
Psychosis
75%
Symptom
48%
Body Mass Index
36%
Follow up
32%
Therapeutic Procedure
32%
Treatment Response
28%
Obesity
25%
Diagnosis
22%
Biological Marker
21%
Lifestyle
18%
Cannabis Use
18%
Health
18%
Reducing Agent
18%
Prospective Cohort Study
18%
Brain Derived Neurotrophic Factor
18%
Hydrocortisone
18%
Drug Therapy
18%
Repetitive Transcranial Magnetic Stimulation
18%
Health Promotion
18%
Treatment Resistant Depression
18%
Vitamin D Deficiency
18%
Insulin Resistance
18%
Cardiometabolic Risk
18%
Male
18%
Randomized Controlled Trial
18%
Disease
16%
Spontaneous Remission
16%
Clinician
16%
Female
10%
Association
10%
Antipsychotics
10%
Mental Health
10%
Waist-Hip Ratio
8%
Student T Test
8%
Saliva
7%
Dysphoria
7%
Positive Syndrome
7%
Side Effect
7%
Marker
7%
Hemoglobin A1c
6%
Smoking
6%
Early Psychosis
6%
Neuroscience
Brain
54%
Brain-Derived Neurotrophic Factor
40%
Body Mass Index
38%
Gyrification
37%
Risperidone
26%
Bipolar Disorder
23%
Antipsychotic
22%
Olanzapine
22%
Cortisol
18%
Major Depressive Disorder
18%
White Matter
18%
Escitalopram
18%
Insulin
18%
Venlafaxine
18%
Treatment-Resistant Depression
18%
Connectomics
18%
Sertraline
18%
Valproic Acid
18%
Memory Disorder
18%
Cholesterol
12%
Interleukin 6
11%
Interferon
11%
Prolactin
8%
Antidepressant
7%
C-Reactive Protein
7%
Diffusion Tensor Imaging
7%
Pediatric Trauma
7%
Gray Matter
5%
Psychology
Schizophrenia
37%
Longitudinal Study
34%
Cognitive Function
28%
Traumatic Event
18%
Bipolar Disorder
18%
Memory Impairment
18%
Regression Analysis
18%
Neuropsychological Deficit
18%
Psychotic Disorder
17%
Rating Scale
15%
Principal Component Analysis
12%
Physical Health
12%
High-Risk Population
11%
Schizoaffective Disorder
10%
Clinical Utility
9%
Human Brain
9%
Cognitive Process
9%
Cognitive Deficit
9%
Hallucinations
9%
Brain Plasticity
9%
Multiple Linear Regression
6%
Correlation Analysis
6%
Mental Health
5%